Medtronic (MDT) closed at $77.12 in the last trading session, reflecting more than a 2% decline from the prior day. Broadly speaking, 2024 has not been smooth for investors in the Medical Products industry. Rising geopolitical pressure, primarily disruptions around the Red Sea, has increased freight costs and shipping lead times, spelling trouble for MDT and several of its direct competitors, like Abbott (ABT) and Boston Scientific (BSX) , thus putting pressure on their margins.Thankfully, there has been an ...